Myomo (MYO) FCF Margin (2016 - 2025)
Myomo posted quarterly FCF Margin of 28.56% for Q3 2025, down 885.0% year-on-year from 3.64% in Q3 2024, and up 74.46% on a QoQ basis from 111.82% in Q2 2025.
Myomo (MYO) has 10 years of FCF Margin data on file, last reported at 28.56% in Q3 2025.
- For the quarter ending Q3 2025, FCF Margin fell 885.0% year-over-year to 28.56%; the trailing twelve-month figure through Sep 2025 stood at 33.25% (up 456.0% YoY), and the FY2024 full-year result was 14.29%, up 1855.0% from the prior year.
- FCF Margin for Q3 2025 stood at 28.56%, up from 111.82% in the prior quarter.
- Across five years, FCF Margin topped out at 20.76% in Q4 2024 and bottomed at 115.66% in Q2 2021.
- The 5-year median for FCF Margin is 51.87% (2021), against an average of 52.53%.
- The widest annual swing landed in 2021, when FCF Margin soared 31003 bps; it then plunged 8476 bps in 2025.
- A 5-year view of FCF Margin shows it stood at 45.95% in 2021, then tumbled by 33 bps to 61.06% in 2022, then gained by 18 bps to 50.19% in 2023, then jumped by 141 bps to 20.76% in 2024, then plunged by 238 bps to 28.56% in 2025.
- The last three FCF Margin figures came in at 28.56% (Q3 2025), 111.82% (Q2 2025), and 27.23% (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -1.28% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 37.67% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.98% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.44% |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -28.56% |
| Jun 30, 2025 | -111.82% |
| Mar 31, 2025 | -27.23% |
| Dec 31, 2024 | 20.76% |
| Sep 30, 2024 | -19.71% |
| Jun 30, 2024 | -27.06% |
| Mar 31, 2024 | -88.04% |
| Dec 31, 2023 | -50.19% |
| Sep 30, 2023 | -34.82% |
| Jun 30, 2023 | -5.04% |
| Mar 31, 2023 | -54.02% |
| Dec 31, 2022 | -61.06% |
| Sep 30, 2022 | -70.67% |
| Jun 30, 2022 | -73.44% |
| Mar 31, 2022 | -61.34% |
| Dec 31, 2021 | -45.95% |
| Sep 30, 2021 | -51.87% |
| Jun 30, 2021 | -115.66% |
| Mar 31, 2021 | -92.33% |
| Dec 31, 2020 | -30.30% |
| Sep 30, 2020 | -94.59% |
| Jun 30, 2020 | -425.70% |
| Mar 31, 2020 | -243.31% |
| Dec 31, 2019 | -174.78% |
| Sep 30, 2019 | -378.10% |
| Jun 30, 2019 | -263.20% |
| Mar 31, 2019 | -376.51% |
| Dec 31, 2018 | -283.56% |
| Sep 30, 2018 | -413.62% |
| Jun 30, 2018 | -373.44% |
| Mar 31, 2018 | -744.07% |
| Dec 31, 2017 | -2,063.23% |
| Sep 30, 2017 | -382.06% |
| Jun 30, 2017 | -517.14% |
| Mar 31, 2017 | -6,302.76% |
| Dec 31, 2016 | -201.71% |
| Sep 30, 2016 | -713.55% |